{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:40:30Z","timestamp":1780926030605,"version":"3.54.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK112295"],"award-info":[{"award-number":["R01DK112295"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Lipid metabolism is altered in human immunodeficiency virus (HIV) infection and chronic liver diseases, but common and unique pathways have not been elucidated, limiting prevention and treatment strategies. The aim of this study was to discover lipid metabolite signatures for persons with HIV (PWH), PWH with HCV coinfection (PWH-HCV), and individuals with metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD, MASH).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Plasma metabolite profiling was performed in adult participants in 5 cohorts from a single center: PWH (n = 50), PWH-HCV (n = 50), HIV-negative biopsy-proven MASLD (n = 46), and MASH (n = 50), and controls without HIV or chronic liver disease (n = 29). Plasma metabolites were assessed using Biocrates Q500, bile acid, and oxylipin assays. Latent factor analysis along with unadjusted and adjusted logistic regression models were performed. Significance was defined as P value &amp;lt; .05 and false discovery rate &amp;lt; 0.10.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared to controls, 457 of 816 measured metabolites were detected at different levels in PWH, 352 in PWH-HCV, 466 in MASLD, and 487 in MASH. Triglycerides and oxylipins were increased across disease states, but to a higher degree in PWH. PWH-HCV had a distinct metabolite signature with decreased ceramides and sphingomyelins. Levels of bile acid, amino acid, and fatty acid metabolites also differentiated cohorts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Lipid metabolites demonstrated pathways common to, and unique to, HIV, HCV, and MASLD. Further studies will hopefully reveal the pathogenic role of these metabolites in liver disease severity, particularly in PWH with steatotic liver disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf270","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:54:01Z","timestamp":1748001241000},"source":"Crossref","is-referenced-by-count":2,"title":["Plasma Lipid Metabolites Differentiate Metabolic From Viral Chronic Liver Disease"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1024-9040","authenticated-orcid":false,"given":"Kara","family":"Wegermann","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Duke University Health System , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E","family":"Lucas","sequence":"additional","affiliation":[{"name":"Vital Statistics, LLC , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dubois","sequence":"additional","affiliation":[{"name":"Proteomics and Metabolomics Core Facility, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Mangus","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University Health System , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9986-6372","authenticated-orcid":false,"given":"Zhong","family":"Li","sequence":"additional","affiliation":[{"name":"Proteomics and Metabolomics Core Facility, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-7086","authenticated-orcid":false,"given":"Cynthia A","family":"Moylan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Duke University Health System , Durham, North Carolina ,","place":["USA"]},{"name":"Department of Medicine, Durham Veterans Affairs Medical Center , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University Health Network Toronto , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-6975","authenticated-orcid":false,"given":"Susanna","family":"Naggie","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University Health System , Durham, North Carolina ,","place":["USA"]},{"name":"Department of Medicine, Durham Veterans Affairs Medical Center , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2025061312114953200_jiaf270-B1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"2025061312114953200_jiaf270-B2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2025061312114953200_jiaf270-B3","doi-asserted-by":"crossref","first-page":"ofac538","DOI":"10.1093\/ofid\/ofac538","article-title":"Factors associated with liver steatosis in people with human immunodeficiency virus on contemporary antiretroviral therapy","volume":"9","author":"Riebensahm","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2025061312114953200_jiaf270-B4","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1210\/jc.2017-01334","article-title":"HDL cholesterol efflux capacity in newly diagnosed HIV and effects of antiretroviral therapy","volume":"102","author":"Toribio","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025061312114953200_jiaf270-B5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.med.55.091902.104412","article-title":"HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies","volume":"55","author":"Koutkia","year":"2004","journal-title":"Annu Rev Med"},{"key":"2025061312114953200_jiaf270-B6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/infdis\/jiaa246","article-title":"Prevalence and risk factors of moderate-to-severe hepatic steatosis in human immunodeficiency virus infection: the Copenhagen co-morbidity liver study","volume":"222","author":"Kirkegaard-Klitbo","year":"2020","journal-title":"J Infect Dis"},{"key":"2025061312114953200_jiaf270-B7","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3748\/wjg.v22.i6.1953","article-title":"Hepatitis C virus relies on lipoproteins for its life cycle","volume":"22","author":"Grassi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2025061312114953200_jiaf270-B8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis","volume":"16","author":"Perlemuter","year":"2002","journal-title":"FASEB J"},{"key":"2025061312114953200_jiaf270-B9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.25631","article-title":"Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner","volume":"56","author":"Clark","year":"2012","journal-title":"Hepatology"},{"key":"2025061312114953200_jiaf270-B10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3748\/wjg.v24.i11.1269","article-title":"Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals","volume":"24","author":"Noureddin","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2025061312114953200_jiaf270-B11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/QAI.0000000000002359","article-title":"Brief report: relationship between nonalcoholic fatty liver disease and cardiovascular disease in persons with HIV","volume":"84","author":"Kaplan","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1 Suppl","key":"2025061312114953200_jiaf270-B12","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases","volume":"61","author":"Negro","year":"2014","journal-title":"J Hepatol"},{"key":"2025061312114953200_jiaf270-B13","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"2025061312114953200_jiaf270-B14","doi-asserted-by":"crossref","first-page":"1122391","DOI":"10.3389\/fendo.2023.1122391","article-title":"Association of alpha-aminoadipic acid with cardiometabolic risk factors in healthy and high-risk individuals","volume":"14","author":"Desine","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025061312114953200_jiaf270-B15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep4.1188","article-title":"Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: results from discovery and validation cohorts","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol Commun"},{"key":"2025061312114953200_jiaf270-B16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/oby.2009.89","article-title":"Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort","volume":"17","author":"Kashyap","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"2025061312114953200_jiaf270-B17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1194\/jlr.P055640","article-title":"Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis","volume":"56","author":"Loomba","year":"2015","journal-title":"J Lipid Res"},{"key":"2025061312114953200_jiaf270-B18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/hep4.1665","article-title":"Serum bile acid, vitamin E, and serotonin metabolites are associated with future liver-related events in nonalcoholic fatty liver disease","volume":"5","author":"Wegermann","year":"2021","journal-title":"Hepatol Commun"},{"key":"2025061312114953200_jiaf270-B19","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/infdis\/jiaa316","article-title":"Metabolomic signature as a predictor of liver disease events in patients with HIV\/HCV coinfection","volume":"222","author":"Naggie","year":"2020","journal-title":"J Infect Dis"},{"key":"2025061312114953200_jiaf270-B20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2334-13-203","article-title":"Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors","volume":"13","author":"Cassol","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2025061312114953200_jiaf270-B21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"2025061312114953200_jiaf270-B22","article-title":"Oxylipin metabolites as markers of inflammation and liver disease in HCV infection","author":"Naggie","year":"2016"},{"key":"2025061312114953200_jiaf270-B23","doi-asserted-by":"crossref","first-page":"101276","DOI":"10.1016\/j.plipres.2024.101276","article-title":"Oxylipin profiling for clinical research: current status and future perspectives","volume":"95","author":"Parchem","year":"2024","journal-title":"Prog Lipid Res"},{"key":"2025061312114953200_jiaf270-B24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41574-023-00932-2","article-title":"Emerging mechanisms of obesity-associated immune dysfunction","volume":"20","author":"Shaikh","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"2025061312114953200_jiaf270-B25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3390\/antiox12030711","article-title":"Polyunsaturated and saturated oxylipin plasma levels allow monitoring the non-alcoholic fatty liver disease progression to severe stages","volume":"12","author":"Ferrer","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"2025061312114953200_jiaf270-B26","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1007\/s10620-020-06095-8","article-title":"Plasma oxylipins levels in nonalcoholic fatty liver disease","volume":"65","author":"Li","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2025061312114953200_jiaf270-B27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cgh.2023.09.018","article-title":"Longitudinal outcomes associated with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of 129 studies","volume":"22","author":"Chan","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025061312114953200_jiaf270-B28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/ATVBAHA.120.315133","article-title":"Impact of age, menopause, and obesity on oxylipins linked to vascular health","volume":"41","author":"Pauls","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025061312114953200_jiaf270-B29","doi-asserted-by":"crossref","first-page":"111594","DOI":"10.1016\/j.fct.2020.111594","article-title":"The lysine derivative aminoadipic acid, a biomarker of protein oxidation and diabetes-risk, induces production of reactive oxygen species and impairs trypsin secretion in mouse pancreatic acinar cells","volume":"145","author":"Estaras","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"2025061312114953200_jiaf270-B30","first-page":"44","article-title":"Polyamines: functions, metabolism, and role in human disease management","volume":"9","author":"Sagar","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"2025061312114953200_jiaf270-B31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41467-023-36163-2","article-title":"Polyamine metabolism impacts T cell dysfunction in the oral mucosa of people living with HIV","volume":"14","author":"Mahalingam","year":"2023","journal-title":"Nat Commun"},{"key":"2025061312114953200_jiaf270-B32","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.onc.1210796","article-title":"The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death","volume":"27","author":"Banjac","year":"2008","journal-title":"Oncogene"},{"key":"2025061312114953200_jiaf270-B33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0167-5699(92)90156-2","article-title":"HIV-induced cysteine deficiency and T-cell dysfunction\u2013a rationale for treatment with N-acetylcysteine","volume":"13","author":"Droge","year":"1992","journal-title":"Immunol Today"},{"key":"2025061312114953200_jiaf270-B34","doi-asserted-by":"crossref","first-page":"121925","DOI":"10.1155\/2015\/121925","article-title":"Choline and cystine deficient diets in animal models with hepatocellular injury: evaluation of oxidative stress and expression of RAGE, TNF-alpha, and IL-1beta","volume":"2015","author":"Santos","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"2025061312114953200_jiaf270-B35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12986-017-0213-3","article-title":"Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial","volume":"14","author":"Papandreou","year":"2017","journal-title":"Nutr Metab (Lond)"},{"key":"2025061312114953200_jiaf270-B36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0021-9150(99)00128-8","article-title":"Cysteine is a cardiovascular risk factor in hyperlipidemic patients","volume":"146","author":"Jacob","year":"1999","journal-title":"Atherosclerosis"},{"key":"2025061312114953200_jiaf270-B37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.numecd.2020.04.010","article-title":"Cysteine is a better predictor of coronary artery disease than conventional homocysteine in high-risk subjects under preventive medication","volume":"30","author":"Lima","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025061312114953200_jiaf270-B38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12967-022-03760-6","article-title":"Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease","volume":"21","author":"Shao","year":"2023","journal-title":"J Transl Med"},{"key":"2025061312114953200_jiaf270-B39","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3748\/wjg.v23.i15.2771","article-title":"Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease","volume":"23","author":"Dong","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2025061312114953200_jiaf270-B40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00726-014-1894-9","article-title":"Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease","volume":"47","author":"Lake","year":"2015","journal-title":"Amino Acids"},{"key":"2025061312114953200_jiaf270-B41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"key":"2025061312114953200_jiaf270-B42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2025061312114953200_jiaf270-B43","doi-asserted-by":"crossref","first-page":"e64298","DOI":"10.1371\/journal.pone.0064298","article-title":"Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapy","volume":"8","author":"Munshi","year":"2013","journal-title":"PLoS One"},{"key":"2025061312114953200_jiaf270-B44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/1570162X20666220428103250","article-title":"Plasma free amino acid profile in HIV-positive cases","volume":"20","author":"Binici","year":"2022","journal-title":"Curr HIV Res"},{"key":"2025061312114953200_jiaf270-B45","doi-asserted-by":"crossref","first-page":"16947","DOI":"10.1038\/s41598-018-35271-0","article-title":"Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy","volume":"8","author":"Peltenburg","year":"2018","journal-title":"Sci Rep"},{"key":"2025061312114953200_jiaf270-B46","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jiy356","article-title":"Gut microbial-related choline metabolite trimethylamine-N-oxide is associated with progression of carotid artery atherosclerosis in HIV infection","volume":"218","author":"Shan","year":"2018","journal-title":"J Infect Dis"},{"key":"2025061312114953200_jiaf270-B47","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1096\/fj.12-219097","article-title":"Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis","volume":"27","author":"Corbin","year":"2013","journal-title":"FASEB J"},{"key":"2025061312114953200_jiaf270-B48","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/aid.2021.0123","article-title":"Untargeted plasma metabolomics reveals extensive metabolic alterations among treatment-naive human immunodeficiency virus\/hepatitis C virus co-infected patients with liver disease progression","volume":"38","author":"He","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025061312114953200_jiaf270-B49","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/liv.14178","article-title":"Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response","volume":"39","author":"Mucke","year":"2019","journal-title":"Liver Int"},{"key":"2025061312114953200_jiaf270-B50","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/apt.17849","article-title":"Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States","volume":"59","author":"Gawrieh","year":"2024","journal-title":"Aliment Pharmacol Ther"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf270\/63308236\/jiaf270.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf270\/63308236\/jiaf270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T16:12:05Z","timestamp":1749831125000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiaf270\/8142318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf270","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"article-number":"jiaf270"}}